IMpower010: Exploratory Analysis of Tumour Mutational Burden and Disease-Free Survival with Adjuvant Atezolizumab in NSCLC

E. Felip, M. Srivastava,M. Reck, H. Wakelee,N. Altorki,E. Vallieres, R. Liersch,S. Oizumi,H. Tanaka,J. T. Hamm,S. Novello,S. McCune,L. Molinero,V. McNally, S. Morris, M. Ballinger, H. Li,W. Zou, B. J. Nabet,E. Bennett, B. J. Gitlitz

JOURNAL OF THORACIC ONCOLOGY(2023)

引用 0|浏览0
暂无评分
关键词
NSCLC,PD-L1,tumour mutational burden
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要